1Thomas A,EI Rouby S,Reed JC,et al.Drug induced apoptosis in B-cell chronic lymphocytic leukemia:relationship between p53 gene mutation and bcl-2 precious in drug resistance.Oncogene,1996,12:1055-1062.
2Mor O,Yaron P,Huszar M,et al.Absence of p53 mutation in maglinant mesotheliomas.Am J Respircell Mol Biol,1997,16(1):9-13.
3Momand J,Wu HH,Dasgupta G,et al.MDM2 master regulator of the p53 tumor suppress protein.Gene,2000,242(1/2):15-19.
4Zhu J,Zhang S,Jiang J,et al.Definition of the p53 functional domains necessary for inducing apoptosis.J Biol Chem,2000,275(51):39927-39934.
5Hainaut P,Soussi T,Shomer B,et al.Database of p53 gene somatid mutation in human tumor and cell lines:updated complication and functure prospects.Nucleic Acids Res,1997,25 (1) 151-157.
6Kaghad M,Bonnet H,Yang A,et al.Monoallelically expressed gene related to p53 to 1 p36 a region frequently deleted in ne oblashona and other human cancer.Cell,1997,90(4):809-819.
7Thompson FH,Taetle R,Trent JM,et al.Band 1p36 abnormalities and t(1; 17) in ovarian carcinoma.Cancer Genet Cytogenet,1997,96:106-110.
8White PS,Maris JM,Beltinger C,et al.A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3.Proe Natl Acad Sci,1995,92:5520-5524.
1Kong XT,Choi SH,Inoue A,et al.Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma[].Cancer Research.1997
2Mai M,Yokomizo A,Qian C,et al.Activation of p73 silent allelic in lung cancer[].Cancer Research.1998
3Kovalev S,Marchenko N,Swendeman S,et al.Expression level, allelic origion, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines[].Cell Growth and Differentiation.1998
4Zaika AI,Kovalev S,Marchenko ND,et al.Overexpression of the wild type p73 gene in breast cancer tissues and cell lines[].Cancer Research.1999
5Yokomizo A,Mai M,Tindall DJ,et al.Overexpression of the wild type p73 gene in human bladder cancer[].Oncegene.1999
6Kawano S,Miller CW,Gombart AF,et al.Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation[].Blood.1999
7Singnal R,Ginder GD.DNA methylation[].Blood.1999
8Kaghad M,Bonnet H,Yang A,et al.Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers[].Cell.1997
9Yang HW,Piao HY,Chen YZ,et al.The p73 gene is less involved in the development but in the progression of neuroblastoma[].International Journal of Molecular Medicine.2000
10Corn PG,Kuerbitz SJ,Noesel MWV,et al.Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt’s lymphoma is associated with 5′CpG island methylation[].Cancer Research.1999
1Nozoe T, Korenaga D, Kabashima A,et al. Significance of cychn B1 expression as an independent prognostic indicator of patients with squamous cell carcinoma of the esophagus [Jl. Clin Cancer Res, 2002,8 (3): 817-822.
2Yoshida J, Ishibashi T, Nishio M. G1 cell cycle arrest by amlodipine, a dihydropyridine Ca^2+ channel blocker,in human epidermoid carcinoma A431 cells [J ]. Biochem Pharmacol, 2007, 73 (7): 943-953.
3Ahmad N, Adhami VM, Afag F, et ol. Resveratrol causes WAF-1/p21-mediated G (1)-phase arrest of cell cycle and induction of a- poptosis in human epidermoid carcinoma A431 cells [J]. Clin Cancer Res, 2001, 7 (5): 1466-1473.
4Liang YC, Tsai SH, Chen L, et al. Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells [J]. Biochem Pharmacol, 2003, 65 (7): 1053-1060.
5Juvan R, Hudler P, Gazvoda B, et ol. Significance of genetic abnormalities of p53 protein in Slovenian patients with gastric carcinoma [J].Croat Med J, 2007, 48 (2): 207-217.
6Chang YL, Wu CT, Lin SC, et al. Clonality and prognostic implications of p53 and epidermal growth factor receptor somatic aberrations in multiple primary lung cancers [J]. Clin Cancer Res, 2007, 13 (1): 52-58.
7Yu M, Zhan Q, Finn OJ. Immune recognition of cyclin B1 as a tumor antigen is a result of its overexpression in human tumors that is caused by non-functional p53 [J]. Mol Immunol, 2002,38 (12-13): 981-987.
8Sorfia JC, Jang SJ, Khuri FR, et al. Overexpression of cyclin Blin early-stage non-small cell lung cancer and its clinical implication [J]. Cancer Res, 2000, 60 (15): 4000-4004.
9Takeno S, Noguchi T, Kikuchi R, et al. Prognostic value of cyclinB1 in patients with esophageal squamous cell carcinoma [J]. Cancer, 2002,94 ( 11 ) : 2874-2881.
10Zhao M, Kim YT, Yoon BS, et al. Expression profiling of cyclin B1 and D1 in cervical carcinoma [J]. Exp Oncol, 2006, 28 (1): 44 - 48.
